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ABSTRACT 
 
Clinical deterioration during the course of community-acquired infections can occur as a 
result of an exaggerated immune response of the host towards the inciting pathogens, 
leading to immune-mediated tissue damage. Whether a surge in the peripheral 
lymphocyte count can be used as a surrogate marker indicating the onset of 
immunopathological tissue damage is not known. In this study, we reported the clinical 
presentations and outcomes of a cohort of immunocompetent patients with non-
tuberculous community acquired infections who experienced clinical deteriorations 
during hospital stay (N=85). 12 (14.1%) patients had a surge in lymphocyte count 
preceding their clinical deteriorations, and their diagnoses included viral pneumonitis (4), 
viral encephalitis (3), scrub typhus (2), leptospirosis (1), brucellosis (1), and dengue 
hemorrhagic fever (1). The clinical manifestations during deterioration ranged from 
interstitial pneumonitis (6), airway obstruction (1), CNS disturbances (4), and systemic 
capillary leak syndrome (1), all of which were thought to represent immunopathological 
tissue damages. When compared with patients without lymphocyte surge, these patients 
were more likely to be infected with fastidious / viral pathogens (0 vs 12; p <0.05), in 
addition to having lower mean baseline lymphocyte counts (403 ± 181 vs 1143 ± 686 
cells/µL; p <0.05). We postulate that the peripheral lymphocyte count may be a useful 
surrogate marker indicating the presence of immunopathological damage during clinical 
deterioration in certain infectious diseases.  
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INTRODUCTION 
The outcome of clinical infectious diseases depends on both the virulence of the microbes 
and the appropriateness of host immune responses.  An intact innate immunity with or 
without subsequent adaptive immunity towards the infecting organisms remains the most 
important factor in eradicating or controlling the infections.  However, clinical 
deterioration as a result of immunopathological damage may occur as a result of an 
overwhelming rebound of the immune system, either temporally related to the withdrawal 
of immunosuppressive therapy such as steroid or cytotoxic agents, or secondary to 
treatment of microbes with potent immunosuppressive effects on the host such as HIV.  It 
is manifested as immunorestitution disease, which has been described in previous studies 
[1,2,3].   In addition, immune-mediated tissue damage can also develop in either 
immunosuppressed or immunocompetent patients infected with Mycobacterium 
tuberculosis, with disease manifestation or exacerbation during anti-tuberculosis therapy, 
a phenomenon that has been given the term ‘paradoxical response’ [4-9].  Recent studies 
showed that an upsurge of the absolute lymphocyte counts and conversion of tuberculin 
skin test from negative to positive occurred during paradoxical deterioration [10,11], 
even for patients co-infected with HIV [7].  A low baseline lymphocyte count with a 
subsequent greater upsurge is one of the risk factors for development of a paradoxical 
response [5].   
  
Apart from tuberculosis, clinical deterioration during the course of illness can also occur 
in immunocompetent patients affected by certain infectious diseases, giving rise to so-
called biphasic illness patterns.  For instance, leptospirosis is characterized by an initial 
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bacteremic phase lasting 4 to 7 days, may be followed by an immune-mediated 
meningitis, uveitis, and pneumonitis, causing multiple organ failure [12,13].  Dengue 
virus infection may also present with ‘saddleback' biphasic fever pattern, followed by 
increased vascular permeability which can result in hypovolemic shock in some cases 
[14].    However, the association of an upsurge of absolute lymphocyte count with 
clinical deterioration in these patients has not been reported. 
 
In this article, we report a cohort of immunocompetent patients with non-tuberculous 
community acquired infections in whom clinical deterioration occurred during an upsurge 
of the absolute lymphocyte count.  The clinical spectrum of this phenomenon and its 
possible mechanisms are discussed.   
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MATERIALS AND METHODS 
Patients 
All clinical data were collected prospectively over a 24-month period (January 2000 – 
December 2001) on patients referred for infectious disease (ID) consultation in a tertiary 
hospital (Queen Mary Hospital, Hong Kong, a 1,350-bed teaching hospital).   
 
Definition of clinical deterioration involving upsurge of lymphocyte count 
For the purpose of this study, clinical deterioration involving upsurge of the lymphocyte 
count was defined as an acute symptomatic deterioration of a (presumably) pre-existing 
infection, which is temporally related to an increase in the absolute lymphocyte count.  
The acute symptomatic deterioration included worsening of neurological symptoms such 
as mental confusion, disorientation, and convulsions; worsening of respiratory symptoms 
such as respiratory distress and development of pulmonary infiltrates and pleural 
effusion; and hypotension with multiple organ failure.    
Surge in absolute lymphocyte count was defined as rise of lymphocyte count of ≥ 500 
cells / μL if the baseline lymphocyte count was less than 500 cells / μL, or double the 
baseline value when the lymphocyte count was more than 500 cells / μL, within a 2-day 
period.   
 
Exclusion criteria 
Patients receiving immunosuppressive therapy (systemic steroids, cytotoxic agents, a 
combination of steroid and cytotoxic agents, or irradiation) or known to have 
immunodeficiency or infected with HIV were excluded from this study as these 
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conditions may suppress the absolute lymphocyte count.  Patients with chronic diseases 
such as diabetes mellitus, chronic renal failure, and chronic liver disease were also 
excluded from this study as they may have abnormal lymphocyte function.  Patients with 
nosocomial infections were excluded because in-patient interventions may result in 
changes in lymphocyte count.  Patients with diagnosis of M. tuberculosis infections were 
also excluded as they were analyzed separately in the context of paradoxical response 
[4,5,10] 
 
Time to development of clinical deterioration involving upsurge of lymphocyte count 
The time to development of clinical deterioration involving upsurge of lymphocyte 
counts was defined as the interval between the initial clinical symptoms and the onset of 
symptomatic deterioration as defined above. 
The consultation procedure has been described previously [15,16]. Briefly, detailed 
history taking, physical examination and review of case notes were performed for each 
patient. Serial lymphocyte counts with subsequent surges, and the occurrence of 
symptomatic clinical deteriorations, were recorded and monitored for each patient. 
 
Statistical evaluation 
The characteristics of patients with or without lymphocyte surge during clinical 
deterioration were compared.  The chi-square test was used for categorical variables.  
Continuous variables were tested by the Student’s t test.  A P value of < 0.05 was 
considered significant.  A statistical package (SPSS 10.0; SPSS Hong Kong, Hong Kong) 
was used for all analyses. 
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RESULTS 
During the 24-month period, there were 3518 inpatient ID consultations, of which 357 
(10.1%) patients with median age of 59, range 2-98, were immunocompetent patients 
with clinical and microbiological evidence of non-tuberculous community acquired 
infections.  Eighty-five patients had clinical deterioration during follow up (table 1).  Of 
these 85 patients, 12 (14.1%) had an upsurge of lymphocyte count during clinical 
deterioration (table 2).  Eight were male and four were female, with median age of 35, 
range 17-75.  Diagnoses in these patients included viral pneumonitis (4), viral 
encephalitis (3), scrub typhus (2), leptospirosis (1), brucelllosis (1), and dengue 
hemorrhagic fever (1) (table 2).  The median duration between the onset of symptoms to 
diagnosis was 6 days (8 days for bacterial infections and 2.5 days for viral infections).  
The median time of clinical deterioration was 10 days from symptom onset.  But the 
median ‘time to clinical deterioration’ was 6 days and 11.5 days for viral and bacterial 
infection respectively.  The clinical manifestations during deterioration included acute 
respiratory distress syndrome as a result of interstitial pneumonitis (6), severe upper 
airway obstruction (1), mental confusion with or without convulsions (4), and capillary 
leak syndrome (1).  When compared with patients without lymphocyte surge, these 
patients were more likely to be suffering from infection by fastidious/intracellular 
bacteria or virus (p < 0.05), in addition to having a lower baseline lymphocyte count (403 
± 181 cells / μL; p < 0.05), a higher lymphocyte count during clinical deterioration (1813 
± 941 cells / μL; p <0.05), and a greater change in lymphocyte count between baseline 
and clinical deterioration (1410 ± 954 cells / μL; p <0.05).  Although empirical 
antibiotics or antiviral agents were initiated in 8 (66.6%) out of 12 patients, appropriate 
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antibiotics or antiviral agents were given in 5 patients after the onset of clinical 
deterioration.  One out of 12 patients died of adult respiratory distress syndrome, whereas 
3 (25%) of them developed permanent functional deficits including left-sided 
hemiparesis, impairment of cognitive function, and chronic renal failure.  The median 
length of stay in hospital was 24 days, range 8-269.   
 
Case reports 
Case 1  
A 29 year-old man was admitted to hospital for persistent high swinging fever and 
headache 9 days after occupational exposure to a scrub area in Hong Kong.  On 
admission, he had a temperature of 38.3oC.  Physical examination revealed conjunctival 
haemorrhage, diffuse maculopapular rash, hepatomegaly, and a 2 cm eschar on his right 
shin.  Preliminary investigations showed a normal white cell count (7110 cells / μL, 
normal range 400-1100 cells / μL) but his lymphocyte count was depressed (370 cells / 
μL, normal range 150-400 cells / μL).  The platelet count was low (47 x 109 /L, normal 
range 150-400 x 109 /L). Liver function tests showed elevated alanine and aspartate 
aminotransferase (ALT) 311 U/L (normal range 6-53 U/L) and aspartate 
aminotransferase levels and renal function was well.   The chest radiograph showed 
pulmonary congestion.  A clinical diagnosis of Rickettsial infection was made and he was 
given doxycycline 100 mg bd.  However, he deteriorated rapidly with progressive liver 
impairment, renal impairment and respiratory distress, and required mechanical 
ventilation in intensive care unit 3 days after admission.  Repeated chest radiographs 
demonstrated acute pulmonary edema.  The hemoglobin dropped from 15.4 g/dL to 12.7 
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g/dL over 3 days and the platelet count further decreased to 36 x 109 /L.  A sudden 
upsurge of lymphocyte count (2670 cells / μL) was observed at the time of deterioration, 
which further increased to 3250 cells / μL.    The clinical features were compatible with 
endothelitis, capillary leak syndrome and multiple organ failure as a result of 
immunopathological damage due to severe rickettsial infection.  After receiving 
antibiotics and methylprednisolone, he gradually recovered.  His lymphocyte count 
decreased to 1200 cells / μL on the day of extubation.   He had positive Orientia 
tustusgamushi IgM serology by immunofluoresence and the Weil-Felix OXK component 
demonstrated a four-fold rise in titre from 1:80 to 1:320 over a 2-week interval.     
Case 2 
A 27-year-old man presented with fever, chills, and abdominal discomfort 7 days after 
occupational exposure to a scrub area in Hong Kong.  On admission, he was alert but had 
a temperature of 38oC.  Physical examination showed maculopapular rash, hepatomegaly, 
and a 1 cm eschar in his right groin.  Preliminary investigations revealed a total white cell 
count of 5600 cells / μL with lymphopenia (300 cells / μL).  The platelet count was low 
(27 x 109 /L). Liver function tests were deranged whereas renal function tests were 
normal.  A clinical diagnosis of Rickettsial infection was made and he was given 
doxycycline 100 mg bd. However he deteriorated rapidly with respiratory distress, and 
required mechanical ventilation in the intensive care unit for 3 days after admission.  A 
chest radiograph demonstrated acute pulmonary edema.  On the day of deterioration, 
there was a sudden upsurge of lymphocyte (3700 cells / μL), which further increased to 
3900 cells / μL one day later.    The clinical features were compatible with endothelitis 
and capillary leak as a result of immunopathological damage secondary to severe 
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rickettsial infection.  He was given intravenous minocycline 100 mg q12h and 
levofloxacin 500 mg q24h.  He subsequently improved and was extubated after 5 days of 
mechanical ventilation.  The lymphocyte count decreased to 1500 cells / μL on the day of 
extubation.  He had positive Orientia tustusgamushi IgM serology and the Weil-Felix 
OXK component demonstrated a three fold serial elevation from 1:20 to 1:160 over a 2-
week interval.  He had a full recovery after a 4-week course of doxycycline 100 mg bd. 
Case 3 
A 39-year-old man presented with fever, generalized malaise, bilateral calf pain, and 
abdominal discomfort 6 days after a heavy rainstorm with flooding in the city.  On 
admission, he had conjuctival suffusion and hepatomegaly.  Investigations showed a 
normal white cell count (8700 cells / μL), but the lymphocyte count was decreased (400 
cells / μL).  His platelet count was 35 x 109 /L.  The liver function was mildly elevated.  
The renal function tests were normal.  A clinical diagnosis of leptospirosis was made and 
he was given intravenous penicillin 1 MU q6h.  Fever subsided after 3 days of therapy.  
On day 5, however, he rapidly deteriorated with recurrent fever, hypotension and 
deranged liver and renal function.  A chest radiograph revealed bilateral pulmonary 
infiltrates.  A sudden surge in the lymphocyte count from 400 to 1100 cells / μL was 
observed on the day of deterioration.  He was continued with intravenous penicillin for 1 
week and recovered after a 2-month convalescent period.  IgM antibodies to Leptospria 
interrogans were demonstrated by enzyme-linked immunosorbent assay.  
Case 4 
A 72-year-old lady with a history of dementia presented with low-grade fever, poor 
appetite, malaise, and generalized bone pain for 2 weeks.  On admission, she was found 
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to have pancytopenia with hemoglobin of 7.5 g/dL, a total white cell count of 3100 cells / 
μL (lymphocyte of 300 cells / μL), and a platelet count of 48 x 109 /L.  Hematological 
malignancy was suspected but bone marrow examination was unremarkable.  On day 8, 
while her lymphocyte count surged to 1200 cells / μL, she became mentally confused, 
and disorientated in time, place, and person.  Lumbar puncture was not performed 
because of thrombocytopenia.  She was given intravenous cefoperzone-sulbactam 1 gm 
q8h as empirical therapy but fever persisted.  Serological evidence of brucellosis was 
obtained by serum agglutination test, in which there was a 4-fold rise in BM from 1:20 to 
1:320 over a 10-day interval.  Magnetic resonance imaging of brain revealed diffuse 
ischemia in brainstem and thalamus.  She was treated as neurobrucellosis with 
doxycycline 100 mg bd and rifampicin 600 mg qd for 6 months.  Both her mental state 
and pancytopenia recovered with therapy.  She probably acquired the infection by 
ingestion of raw meat because of inadequate cooking. 
Case 5 
A 33-year-old man presented with fever, chills, headache, sore throat, cough and myalgia 
7 days after returning from Bangladesh.  Physical examination revealed a fine diffuse 
macular rash over the body.  On admission, he had a normal white cell count (8400 cells / 
μL) but had lymphopenia (400 cells / μL).  His platelet count was 168 x 109 /L and the 
liver and renal function tests were normal.  A clinical diagnosis of dengue fever was 
made.  However, he had a progressive drop in platelet count (25 x 109 /L) and blood 
pressure after 3 days of admission.  A chest radiograph revealed bilateral pleural 
effusions.  A surge of the lymphocyte count (2100 cells / μL) was observed on the day of 
deterioration.  The liver function tests were also deranged when assayed 3 days after the 
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upsurge of lymphocytes.  He gradually improved and pleural effusion resolved after 1 
month.  Paired serum demonstrated a rising titer from < 10 to 1:2560 towards dengue 
type 2 over a 4-day interval.  The dengue PCR on his acute serum was also positive. 
Case 6 
A 75-year-old man presented with painful reactivation of varicella zoster in the 
dermatomal distribution of L1.  On admission, he was conscious and afebrile.  The white 
cell count was normal (4100 cells / μL), but the lymphocyte count was low (700 cells / 
μL).  He was given oral famciclovir 500 mg tds and the skin lesions gradually subsided.  
However, after 10 days of therapy, he developed generalized malaise, mental confusion, 
and convulsions, suggestive of encephalitis.  The lymphocyte count increased to (1600 
cells / μL) on the day of deterioration.  Cerebrospinal fluid (CSF) revealed lymphocytic 
pleocytosis with a total cell count of 293 cells / μL and a lymphocyte count of 201 cells / 
μL.  His CSF was polymerase chain reaction (PCR) positive for varicella zoster virus but 
a viral culture of CSF was negative.  He gradually improved with intravenous acyclovir 
500 mg q8h for 14 days. 
Case 7 
A 27-year-old man presented with neck pain, neck stiffness, and progressive headache for 
1 week.  On admission, he had a temperature of 37.6 oC.  The white cell count and 
lymphocyte count were 5610 and 760 cells / μL respectively.  Lumbar puncture revealed 
a total cell count of 819 and a lymphocyte count of 606 cells / μL.  He was treated with 
intravenous acyclovir 500 mg ivi q8h.  On day 3, he developed mental confusion with a 
surge in peripheral lymphocyte count to 2000 cells / μL.  Anti-tuberculous therapy was 
started in view of the clinical deterioration.  He gradually improved neurologically after 1 
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weeks of acyclovir and 4 days of anti-tuberculous treatment.  CSF was PCR positive for 
HSV and for mycobacteria.  Anti-tuberculous drugs were withheld and he fully recovered 
after 21 days of acyclovir. 
Case 8 
A 35-year-old woman presented with a 3-day history of fever, headache, nausea, and 
vomiting.  On admission, she was mentally alert.  Physical examination was 
unremarkable except for a low-grade fever of 37.8 oC.  Her white cell count was normal 
(6200 cells / μL) and the lymphocyte count was low (500 cells / μL).  On day 3, she 
developed mental confusion with auditory hallucination and convulsion.  Computerized 
tomography of brain revealed a 3 cm hypodense lesion in the right temporal area.  
Magnetic resonance scanning showed an abnormal right temporal lobe with mild 
hypointense signal on T-1 weighted image and a heterogeneous hyperintense signal on T-
2 weighted image, consistent with encephalitis.  CSF showed a total cell count of 130 
cells / μL and lymphocyte of 125 cells / μL.  Her blood lymphocyte count increased from 
500 to 1400 cells / μL on the day of deterioration.  She was treated with intravenous 
acyclovir 500 mg q8h for 21 days and recovered with a residual deficit in abstract 
thinking.  The CSF was HSV-1 PCR positive. 
Case 9 
A 71-year-old woman was admitted for a 2-day history of sore throat and nonproductive 
cough.  On admission, the white cell and lymphocyte counts were 2900 and 300 cells / 
μL respectively.  She was treated conservatively as community acquired viral infection.  
However, two days after admission, she deteriorated with respiratory distress and 
inspiratory stridor requiring mechanical ventilation.  Her lymphocyte count surged from 
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300 to 800 cells / μL at the time of deterioration.  Bronchoscopic examination showed 
swollen vocal cords and subglottic edema.  A nasopharyngeal aspirate for direct antigen 
detection was positive for parainfluenza virus type 3.  She required prolonged ventilation 
for 28 days and finally recovered on day 35. 
Case 10 
A 17-year-old female with mental retardation presented with flu-like symptoms for 2 
days.  On admission, her white cell count was normal (5600 cells / μL), with a depressed 
lymphocyte count (300 cells / μL).  A chest radiograph was unremarkable.  On day 3, she 
developed progressive respiratory distress and required mechanical ventilation.  The 
chest radiograph showed bilateral interstitial opacities suggestive of pneumonitis.  At the 
time of deterioration, her lymphocyte count increased from 1300 (day 3) to 3180 cells / 
μL (day 5).  A nasopharyngeal aspirates showed influenza A virus by direct antigen 
detection.  She succumbed on day 10 from adult respiratory distress syndrome despite 
therapy with amantidine and intravenous cefotaxime.   
Case 11 
A 67-year-old man with a history of chronic obstructive airway disease (COAD) was 
admitted complaining of shortness of breath for 2 days.  On admission, his lymphocyte 
count was 400 cells / μL and the chest radiograph showed hyperinflated lung fields.  He 
was diagnosed as having an exacerbation of COAD, and treatment with bronchodilators. 
Three days after admission he developed worsening respiratory distress, and a chest 
radiograph revealed interstitial pneumonitis. This was associated with a surge in the 
lymphocyte count of 1100 cells / μL.  He was intubated and mechanically ventilated in 
the intensive care unit.  A nasopharyneal aspirate was positive for influenza A virus by 
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direct antigen detection.  He was extubated on day 7 and transferred to a convalescent 
hospital for further management. 
Case 12 
A 64-year-old man with an underlying history of chronic obstructive airway disease was 
admitted to hospital for increasing shortness of breath for 1 week.  On admission, he was 
noted to have leucocytosis (white cell count 13700 cells / μL) and lymphopenia (total 
lymphocyte count 100 cells / μL).  He was diagnosed as having a COAD exacerbation 
and treated with bronchodilators.  Three days after admission he deteriorated with 
increasing respiratory distress, and chest radiographs revealed bilateral interstitial 
pneumonitis. He developed progressive respiratory failure and was subsequently 
intubated and mechanically ventilated.  The lymphocyte count surged to 900 μ/L.  A 
nasopharyngeal aspirate was positive for respiratory syncytial virus.  He gradually 
recovered after 8 days of ventilation. 
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DISCUSSION 
Clinical deterioration associated with lymphocyte surge is not a rare phenomenon, 
especially in the context of certain infectious diseases [1-4,10].  In our experience, it 
constitutes 14% of immunocompetent hosts who experienced clinical deterioration during 
the course of community-acquired infections.  In addition to the classical examples of 
leptospirosis and dengue virus infection in which a “biphasic” clinical pattern may occur, 
infections caused by fastidious/intracellular bacteria such as Orientia tsutsugamushi, 
Brucella species, and other commonly encountered viruses such as influenza A virus, 
parainfluenza virus, respiratory syncytial virus, herpes simplex virus and varicella zoster 
virus were also observed in our patients with clinical deterioration during the course of 
illness.  Endothelium-rich organs such as lungs and brain were the most commonly 
involved systems during clinical deterioration.   
 
It is not surprising to observe an upsurge of the lymphocyte count in patients suffering 
from fastidious/intracellular bacteria and viruses because an adaptive immune response is 
required for their clearance [17].  However, the clinical outcome of infection is dependent 
on the appropriateness and exactness of the development of adaptive immunity.  An 
overwhelming and exaggerated immune response may lead to excessive 
immunopathological damage at the tissue level [1].  This phenomenon is exemplified by 
scrub typhus, caused by O. tsutsugamushi, which is a gram negative obligate intracellular 
bacterium transmitted by the bites of infected mite.    The pathologic damage of scrub 
typhus included disseminated vasculitis and perivasculitis of small blood vessels as a 
result of direct invasion and proliferation of O. tsutsugamushi in the vascular endothelial 
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cells, which may lead to multiple organ failure [24].  In experimental studies, transient 
immunosuppression occurred during acute infection [18]. Subsequent development of 
specific T lymphocytic response, especially T-helper 1 cells, and development of delay-
type hypersensitivity were important for protective immunity [20-23].    However, an 
overwhelming immune response may contribute to the development of acute respiratory 
distress syndrome, which is caused by interstitial infiltration of lymphocytes without any 
evidence of vasculitic damage [25].  However, the serial lymphocyte counts were not 
mentioned during clinical deterioration in these case reports.  
 
As for viral infection, dengue hemorrhagic fever occurred as a result of massive T 
lymphocyte activation leading to high level of inflammatory cytokine production such as 
interferon γ, interleukin 2, tumor necrosis factor α.  Overproduction of cytokines that 
affect monocytes, endothelial cells, and hepatocytes may result in capillary leakage and 
deranged liver function [26,27]. Development of T cell mediated immunity in respiratory 
virus infection has been associated with immunopathological damage in lungs in various 
experimental models [28,29].  Influenza infection in CD8 T-cell depleted mice presented 
with less significant histological evidence of inflammatory injury which suggested that 
host T cells played a role in the immunopathological process [30].  Further study 
demonstrated that antigen-specific CD8 T cells were capable of recognizing an alveolar 
epithelial autoantigen, which triggered an inflammatory cascade and resulted in lung 
damage [31].  In contrast to CD8 T cell mediated damage in influenza virus infection, 
CD4 T cells have been shown to be detrimental to the host by mediating 
immunopathological damage in respiratory syncytial virus infection [32]. 
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It is possible that the upsurge in lymphocyte count may have been caused by specific 
microbial components or products. One interesting example illustrating some of the 
potential mechanisms may be found in the model of pertussis infection. Infection by 
Bordetella pertussis has been reported to result in peripheral blood lymphocytosis in 
infants [33,34]. The expression of L-selectin (CD62L), an important cell surface adhesion 
molecule mediating extravasation of blood lymphocytes into tissues and homing of 
lymphocytes to lymph nodes, has been found to be marked reduced in infants with 
pertussis infection [33,34]. In addition, it has been shown in animal models that 
expression of other lymphocyte adhesion molecules such as CD11a and CD18 (LFA-1) 
are also reduced in macaques treated with pertussis toxin [35]. The significant down-
regulation of these adhesion molecules may prevent lymphocyte migration to areas of 
infection and homing of T and B cells to peripheral lymphoid tissues, resulting in 
peripheral blood lymphocytosis.  
 
In additional to the microbial factors, specific host factors might have contributed to the 
upsurge in lymphocytes. Various cytokine levels can affect the lymphocyte count; for 
instance, increase in lymphocyte count has been shown to correlate with response to 
interleukin 2 therapy for malignant conditions [36,37]. Even acute stress may lead to 
changes in lymphocyte count as a result of changes in integrin expression and 
lymphocyte trafficking in the body [38]. Thus, it is possible that the cytokine response or 
stress induced by some of the microbes may have contributed to the lymphocyte upsurge. 
However, the scope of our study does not allow us to measure the various cytokine levels 
or to determine the pattern of expression of adhesion molecules on the lymphocytes. 
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 Besides having lymphocyte upsurge during hospitalizations, many of our patients also 
had low lymphocyte counts on admission. Lymphopenia is not uncommonly observed in 
the acute phase of viral infections, such as during infection by respiratory syncytial virus 
[39], avian influenza [40] and even SARS [41]; in can also occur in the setting of severe 
sepsis [42]. One limitation of our study is that we could not differentiate whether the 
lymphocyte upsurge observed in our patients actually reflect initial migration of 
lymphocytes to infected tissues followed by subsequent rebound, or the effect of 
microbial and/or cytokine mediated lymphocyte apoptosis followed by reconstitution 
later in disease course. Further studies are warranted to delineate the underlying 
immunopathological mechanisms involved in this interesting phenomenon. 
 
The exact mechanism mediating the immunopathology in various types of clinical 
infectious diseases requires further investigation.  However, peripheral lymphocyte 
counts may act as a surrogate marker indicating the onset of possible 
immunopathological damage, which may be useful to infectious disease specialists who 
are involved in the care of these patients.  Studies on lymphocyte subsets and cytokine 
levels would be useful in understanding this clinical entity.    
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Table 1. Characteristics of immunocompetent patients with clinical deterioration 
following culture-documented community acquired infection  
 Patients without 
upsurge of 
lymphocyte 
counts 
(n = 73) 
Patients with 
upsurge of 
lymphocyte 
counts 
(n=12) 
 
P value 
Age (mean ± S.D.) 59.7 ± 20.0 46.3 ± 21.5 NS 
Sex (male: female) 1.5: 1 2: 1 NS 
    
Predominant infecting microbes     
Non-fastidious bacteria 73 0 < 0.05 
Fastidious bacteria 0 4 * < 0.05 
Viruses  0 8 # < 0.05 
    
Reasons for clinical deterioration    
Primary infective complications 21 0 0.03 
Nosocomial infective complications 32 0 < 0.05 
Antibiotic side effects 13 0 NS 
Others non infective complications 7 12 < 0.05 
Acute respiratory distress syndrome 0 6 < 0.05 
Upper airway obstruction  0 1 < 0.05 
Mental confusion +/- convulsion 0 4 < 0.05 
Capillary leak syndrome  0 1 < 0.05 
Gastrointestinal bleeding 3 0 NS 
Deep vein thrombosis 2 0 NS 
Atrial fibrillation 1 0 NS 
Accidental fracture  1 0 NS 
    
Baseline lymphocyte count (cells/μL), mean 
± S.D. 
 
1143 ± 686 403 ± 181 < 0.05 
Lymphocyte count at clinical deterioration 
(cells/μL), mean ± S.D. 
 
1081 ± 539＃ 1813 ± 941 < 0.05 
Change in lymphocyte count between 
baseline and clinical deterioration (cells/μL), 
mean ± S.D. 
 
335 ± 304 1410 ± 954 < 0.05 
* Brucella species (1), Leptospira species (1), Orientia tsutsugamushi (2); # dengue virus 
(1), herpes simplex virus (2), influenza A virus (2), parainfluenza virus (1), respiratory 
syncytial virus (1), varicella zoster virus (1). 
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Table 2.  Characteristics of patients with clinical deterioration associated with upsurge of lymphocyte 
Case 
no. 
Sex / 
age 
Infectious 
diagnosis 
(organisms) 
Lym 
count - 
baseline 
(cells/ 
μL) 
Lym 
count - 
during 
deterior
ation 
(cells/ 
μL) 
 
Duration 
between 
onset of 
symptom 
to  
diagnosis 
Duration 
between 
onset of 
symptom 
to 
deteriorati
on 
Antimicrobial 
therapy before 
deterioration 
Clinical features 
during deterioration 
Therapy after 
deterioration  
Outcome & 
(length of 
stay in 
hospital) 
1 M/29 Scrub typhus 
(Orientia 
tsutsugamushi) 
370 2670 9 days 12 days Doxycycline 
given 2 day 
before 
deterioration 
Respiratory distress, 
interstitial 
pneumonitis requiring 
mechanical 
ventilation, acute liver 
and renal failure 
 
Chloram-
phenicol, 
minocycline, 
levofloxacin, 
methy-
prednisolone 
Recovered 
(72 days) 
2 M/27 Scrub typhus 
(Orientia 
tsutsugamushi) 
300 3700 7 days 10 days Doxycycline 
given 2 day 
before 
deterioration 
 
Respiratory distress, 
interstitial 
pneumonitis requiring 
mechanical ventilation 
 
Doxycycline Recovered 
(24 days) 
 
3 M/39 Leptospirosis 
(Leptospira 
interrogans) 
400 1100 6 days 11 days Penicillin 
given 5 days 
before 
deterioration 
Respiratory distress, 
interstitial 
pneumonitis, acute 
liver and renal failure 
Penicillin  Recovered 
with residual 
renal 
dysfunction 
(17 days) 
 
4 F/72 Brucellosis 300 1200 38 days 22 days Cefoperazone-
sulbactam 2 
days before 
deterioration  
 
Mental confusion, 
disorientation in time, 
place, and person 
Doxycycline, 
rifampicin for 6 
months 
Recovered 
(269 days) 
5 M/33 Dengue 
hemorrhage 
fever (Dengue 
virus) 
400 2100 3 days 6 days Nil Pleural effusion, 
thrombocytopenia,  
liver dysfunction 
 
Supportive  Recovered 
(8 days) 
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6 M/75 Varicella 
encephalitis 
(varicella-
zoster virus) 
700 1600 1 day 10 days Famciclovir 
given 10 days 
before 
deterioration 
Mental confusion & 
convulsion 
Intravenous 
acyclovir   
Recovered 
with residual 
lower limbs 
weakness 
(26 days) 
 
7 M/27 Herpes 
simplex 
encephalitis 
(herpes 
simplex virus) 
 
760 2000 7 days 10 days Acyclovir 1 
day before 
deterioration 
Mental confusion Intravenous 
acyclovir   
Recovered 
(17 days) 
8 F/35 Herpes 
simplex 
encephalitis 
(herpes 
simplex virus) 
 
500 1400 6 days 6 days Amoxicillin-
clavulanate 
Mental confusion, 
auditory hallucination, 
& convulsion 
Intravenous 
acyclovir   
Recovered 
with deficit 
in cognitive 
function  
(19 days) 
9 F/71 Croup 
(parainfluenza 
virus type 3) 
 
300 800 2 days 4 days Nil Severe croup with 
upper airway 
obstruction 
Supportive Recovered 
(32 days) 
10 F/17 Viral 
pneumonitis 
(influenza A 
virus) 
 
300 3180 2 days 7 days Amoxicillin-
clavulanate 
Respiratory distress, 
interstitial 
pneumonitis requiring 
mechanical ventilation 
 
Amantadine, 
supportive 
Died  
(30 days) 
11 M/70 Viral 
pneumonitis 
(influenza A 
virus) 
 
400 1100 2 days 5 days Nil Respiratory distress, 
interstitial 
pneumonitis requiring 
mechanical ventilation 
 
Supportive  Recovered 
(11 days) 
12 M64 Viral 
pneumonitis 
(respiratory 
syncytial 
virus)  
100 900 8 days 11 days Nil Respiratory distress, 
interstitial 
pneumonitis requiring 
mechanical ventilation 
 
Supportive Recovered 
(29 days) 
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